WHO WE ARE
Qureator’s Microphysiological systems (MPS) provide high-throughput 3D disease-relevant phenotypic models to recapitulate important physiological characteristics and reproduce complex disease states using human cells.
Recent Financing Round :
$15 Million Series A in April 2022
Other Investors :
Winvest Venture Capital, HG Initiative (HGI)
Portfolio company :